Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle development and microbes help regulatory T cells gather in newborn skin.

Memory T cells in the skin balance staying put and moving into the blood, clustering around hair follicles, and increasing in number after infection.

Memory regulatory T cells need IL-7, not IL-2, to stay in peripheral tissues.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

New single-cell analysis techniques are improving our understanding of stem cells and could help in treating diseases.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

TGFβ's manipulation of inflammation and immune cells affects cancer spread, suggesting new treatment strategies and biomarkers.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Hair loss in certain young mice is linked to a specific gene and can be caused by lack of iron.

Genetic mutation and carcinogen treatment are both needed for skin cancer to develop in these specific mice.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

PINK1 is important for controlling gut immune responses linked to early Parkinson's disease.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

An elderly man's hair grew back after treatment with secukinumab, possibly due to reduced scalp inflammation or the medication's direct effects.

Low doses of Asiasari radix extract boost stem cell growth without changing their shape.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

HuR is essential for Treg function and preventing autoimmunity.

CD4 is crucial for maintaining skin stem cell balance and aiding wound healing.